Ads
related to: pfizer- Quality by Design
A holistic, proactive approach
to drug development. Learn more.
- Biologics Development
Increase batch yield and reduce
processing time.
- Quality by Design
Search results
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 5 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
The Highest Paid CEOs of 2023
The Wall Street Journal· 2 days agoBottom of the pack Among the 25 worst-performing companies in the Journal analysis, nearly a third operated in the healthcare sector, including six...
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 7 days agoPfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported ...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 5 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
FCB Chicago lays off staff after losing Pfizer ad account
Crain s Chicago Business· 17 hours agoThe Interpublic Group of Cos. agency cuts 9% of staff after losing creative work from the pharma giant earlier this year.
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK
Morningstar· 24 hours agoBy Adriano Marchese Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding ...
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 7 days agoMay 16 (Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued ...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 5 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking...